table of content
1 Introduction to Research & Analysis Reports
1.1 CAR T-Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR T-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-Cell Therapy Overall Market Size
2.1 Global CAR T-Cell Therapy Market Size: 2022 VS 2030
2.2 Global CAR T-Cell Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-Cell Therapy Players in Global Market
3.2 Top Global CAR T-Cell Therapy Companies Ranked by Revenue
3.3 Global CAR T-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 CAR T-Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR T-Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR T-Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 CAR T-Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global CAR T-Cell Therapy Market Size Markets, 2022 & 2030
4.1.2 CD19 - Targeted
4.1.3 BCMA - Targeted
4.2 By Type - Global CAR T-Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global CAR T-Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global CAR T-Cell Therapy Revenue, 2023-2030
4.2.3 By Type - Global CAR T-Cell Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR T-Cell Therapy Market Size, 2022 & 2030
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application - Global CAR T-Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global CAR T-Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global CAR T-Cell Therapy Revenue, 2023-2030
5.2.3 By Application - Global CAR T-Cell Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global CAR T-Cell Therapy Market Size, 2022 & 2030
6.2 By Region - Global CAR T-Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global CAR T-Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global CAR T-Cell Therapy Revenue, 2023-2030
6.2.3 By Region - Global CAR T-Cell Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America CAR T-Cell Therapy Revenue, 2018-2030
6.3.2 US CAR T-Cell Therapy Market Size, 2018-2030
6.3.3 Canada CAR T-Cell Therapy Market Size, 2018-2030
6.3.4 Mexico CAR T-Cell Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe CAR T-Cell Therapy Revenue, 2018-2030
6.4.2 Germany CAR T-Cell Therapy Market Size, 2018-2030
6.4.3 France CAR T-Cell Therapy Market Size, 2018-2030
6.4.4 U.K. CAR T-Cell Therapy Market Size, 2018-2030
6.4.5 Italy CAR T-Cell Therapy Market Size, 2018-2030
6.4.6 Russia CAR T-Cell Therapy Market Size, 2018-2030
6.4.7 Nordic Countries CAR T-Cell Therapy Market Size, 2018-2030
6.4.8 Benelux CAR T-Cell Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia CAR T-Cell Therapy Revenue, 2018-2030
6.5.2 China CAR T-Cell Therapy Market Size, 2018-2030
6.5.3 Japan CAR T-Cell Therapy Market Size, 2018-2030
6.5.4 South Korea CAR T-Cell Therapy Market Size, 2018-2030
6.5.5 Southeast Asia CAR T-Cell Therapy Market Size, 2018-2030
6.5.6 India CAR T-Cell Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America CAR T-Cell Therapy Revenue, 2018-2030
6.6.2 Brazil CAR T-Cell Therapy Market Size, 2018-2030
6.6.3 Argentina CAR T-Cell Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR T-Cell Therapy Revenue, 2018-2030
6.7.2 Turkey CAR T-Cell Therapy Market Size, 2018-2030
6.7.3 Israel CAR T-Cell Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia CAR T-Cell Therapy Market Size, 2018-2030
6.7.5 UAE CAR T-Cell Therapy Market Size, 2018-2030
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR T-Cell Therapy Major Product Offerings
7.1.4 Novartis CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR T-Cell Therapy Major Product Offerings
7.2.4 Gilead Sciences CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News
7.4 J & J
7.4.1 J & J Corporate Summary
7.4.2 J & J Business Overview
7.4.3 J & J CAR T-Cell Therapy Major Product Offerings
7.4.4 J & J CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 J & J Key News
7.5 JW Therapeutics
7.5.1 JW Therapeutics Corporate Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR T-Cell Therapy Major Product Offerings
7.5.4 JW Therapeutics CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 JW Therapeutics Key News
7.6 FOSUNKite
7.6.1 FOSUNKite Corporate Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR T-Cell Therapy Major Product Offerings
7.6.4 FOSUNKite CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 FOSUNKite Key News
7.7 CARsgen Therapeutics (Pipeline)
7.7.1 CARsgen Therapeutics (Pipeline) Corporate Summary
7.7.2 CARsgen Therapeutics (Pipeline) Business Overview
7.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Major Product Offerings
7.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 CARsgen Therapeutics (Pipeline) Key News
7.8 Autolus Therapeutics(Pipeline)
7.8.1 Autolus Therapeutics(Pipeline) Corporate Summary
7.8.2 Autolus Therapeutics(Pipeline) Business Overview
7.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.8.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Autolus Therapeutics(Pipeline) Key News
7.9 Sorrento Therapeutics(Pipeline)
7.9.1 Sorrento Therapeutics(Pipeline) Corporate Summary
7.9.2 Sorrento Therapeutics(Pipeline) Business Overview
7.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.9.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Sorrento Therapeutics(Pipeline) Key News
7.10 Mustang Bio(Pipeline)
7.10.1 Mustang Bio(Pipeline) Corporate Summary
7.10.2 Mustang Bio(Pipeline) Business Overview
7.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.10.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Mustang Bio(Pipeline) Key News
7.11 Bluebird Bio(Pipeline)
7.11.1 Bluebird Bio(Pipeline) Corporate Summary
7.11.2 Bluebird Bio(Pipeline) Business Overview
7.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.11.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Bluebird Bio(Pipeline) Key News
7.12 Cellectis(Pipeline)
7.12.1 Cellectis(Pipeline) Corporate Summary
7.12.2 Cellectis(Pipeline) Business Overview
7.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.12.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Cellectis(Pipeline) Key News
7.13 Allogene Therapeutics(Pipeline)
7.13.1 Allogene Therapeutics(Pipeline) Corporate Summary
7.13.2 Allogene Therapeutics(Pipeline) Business Overview
7.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.13.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 Allogene Therapeutics(Pipeline) Key News
7.14 Celyad(Pipeline)
7.14.1 Celyad(Pipeline) Corporate Summary
7.14.2 Celyad(Pipeline) Business Overview
7.14.3 Celyad(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.14.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.14.5 Celyad(Pipeline) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
